Markku Peraaho
Overview
Explore the profile of Markku Peraaho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dotsenko V, Oittinen M, Taavela J, Popp A, Peraaho M, Staff S, et al.
Cell Mol Gastroenterol Hepatol
. 2020 Aug;
11(1):13-32.
PMID: 32745639
Background & Aims: Gluten challenge studies are instrumental in understanding the pathophysiology of celiac disease. Our aims in this study were to reveal early gluten-induced transcriptomic changes in duodenal biopsies...
2.
Taavela J, Viiri K, Popp A, Oittinen M, Dotsenko V, Peraaho M, et al.
BMC Gastroenterol
. 2019 Nov;
19(1):189.
PMID: 31730447
Background: There is an unmet need for novel treatments, such as drugs or vaccines, adjunctive to or replacing a burdensome life-long gluten-free diet for coeliac disease. The gold standard for...
3.
Ylisaukko-Oja T, Torvinen S, Aaltonen J, Nuutinen H, Blomster T, Jussila A, et al.
Biologicals
. 2019 Feb;
58:50-56.
PMID: 30755369
Limited data is available on vedolizumab combination therapies in real-world clinical practice. Here, we evaluated the concomitant corticosteroid, immunosuppressive, and 5-aminosalicylic acid utilization of inflammatory bowel disease (IBD) patients treated...
4.
Ylisaukko-Oja T, Aaltonen J, Nuutinen H, Blomster T, Jussila A, Pajala M, et al.
Scand J Gastroenterol
. 2017 Dec;
53(2):158-167.
PMID: 29258369
Objectives: The efficacy and tolerability of vedolizumab in the treatment of inflammatory bowel diseases (IBD) has been demonstrated in an extensive GEMINI clinical trial programme. Clinical trials represent highly selected...
5.
Koskinen O, Lindfors K, Collin P, Peraaho M, Laurila K, Woolley N, et al.
Dig Liver Dis
. 2010 Apr;
42(10):692-7.
PMID: 20409763
Background And Aims: The diagnosis of coeliac disease is problematic in individuals not responding to a gluten-free diet. Small-bowel villous atrophy occurs in other enteropathies and non-responsive patients are often...
6.
Khan J, Pikkarainen P, Karvonen A, Makela T, Peraaho M, Pehkonen E, et al.
Scand J Gastroenterol
. 2009 May;
44(8):970-4.
PMID: 19440927
Objective: To assess the aetiology, prognosis and prevalence of spontaneous bacterial peritonitis (SBP) in patients hospitalized for ascites. The validity of an elevated (>11 g/l) serum-ascites albumin gradient (SAAG) in...
7.
Kaukinen K, Peraaho M, Collin P, Partanen J, Woolley N, Kaartinen T, et al.
Scand J Gastroenterol
. 2005 Jul;
40(5):564-72.
PMID: 16036509
Objective: In coeliac disease, autoantibodies directed against transglutaminase 2 are produced in small-bowel mucosa, and they have been found to be deposited extracellularly. The aim of this study was to...
8.
Peraaho M, Collin P, Kaukinen K, Kekkonen L, Miettinen S, Maki M
J Am Diet Assoc
. 2004 Jun;
104(7):1148-50.
PMID: 15215774
Finnish celiac disease and dermatitis herpetiformis patients have used oat-containing gluten-free diets since 1997. The aim of this study was to evaluate how the use of oats has been adopted....